Minimal Residual Disease in Acute Lymphoblastic Leukemia
1 Tampilan
• 06/15/23
0
0
Menanamkan
administrator
Pelanggan
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru